Comments submitted to FDA on Homeopathic Product Regulation: Evaluating the Food and Drug Administration's Regulatory Framework After a Quarter-Century. (Docket Number: FDA-2015-N-0540-7641). Click here to read the comments and impact on ACRP Members.
Comments submitted to FDA on Establishment of the Patient Engagement Advisory Committee. (Docket Number: FDA-2015-N-3166).